(Q35637863)

English

Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial

scientific article published on 10 April 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

ankylosing spondylitis

1 reference

based on heuristic

inferred from title

Gerd-Rüdiger Burmester

5

object named as

G Burmester

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

author name string

J Braun

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

J Zochling

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

X Baraliakos

3

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

R Alten

4

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

K Grasedyck

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

J Brandt

7

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

H Haibel

8

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

M Hammer

9

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

A Krause

10

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

F Mielke

11

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

H-P Tony

12

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

W Ebner

13

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

B Gömör

14

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

J Hermann

15

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

H Zeidler

16

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

E Beck

17

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

M Baumgaertner

18

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

J Sieper

19

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

language of work or name

0 references

publication date

10 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

65

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1147-1153

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

ASAS/EULAR recommendations for the management of ankylosing spondylitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798286

27 July 2018

First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798286

27 July 2018

Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798286

27 July 2018

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798286

27 July 2018

Ankylosing spondylitis and undifferentiated spondyloarthropathies: a clinical review and description of a disease subset with older age at onset.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798286

27 July 2018

A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798286

27 July 2018

A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798286

27 July 2018

Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798286

27 July 2018

The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798286

27 July 2018

Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798286

25 September 2018

The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798286

25 September 2018

Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798286

25 September 2018

Sulfasalazine for ankylosing spondylitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798286

25 September 2018

Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanercept.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798286

25 September 2018

[Adaption and validation of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in Germany]

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798286

25 September 2018

Successful short term treatment of severe undifferentiated spondyloarthropathy with the anti-tumor necrosis factor-alpha monoclonal antibody infliximab.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798286

25 September 2018

Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798286

25 September 2018

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798286

25 September 2018

Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16606646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16606646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population

1 reference

https://pubmed.ncbi.nlm.nih.gov/16606646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup

1 reference

https://pubmed.ncbi.nlm.nih.gov/16606646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16606646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16606646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index

1 reference

https://pubmed.ncbi.nlm.nih.gov/16606646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16606646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Evaluation of a German version of WOMAC (Western Ontario and McMaster Universities) Arthrosis Index]

1 reference

https://pubmed.ncbi.nlm.nih.gov/16606646

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ARD.2006.052878

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35637863&oldid=1582161415"